ERBB2 and neoplasm: Recently, CAR T cells have been shown to mediate significant anti-tumor activity against adult glioblastoma by targeting HER2 or IL13Ra2, which can be employed against pediatric high-grade gliomas (phase I, clinicaltrials.gov: NCT02208362) [93,94].